☆ 4.7 Meeting Abstract

Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

EUROPEAN JOURNAL OF CANCER (2022)

Journal

EUROPEAN JOURNAL OF CANCER

Volume 174, Issue -, Pages S28-S29

Publisher

ELSEVIER SCI LTD

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.